The European Commission has approved the topical pan–Janus kinase inhibitors inhibitor delgocitinib for adults with moderate ...

The FDA has accepted for filing the NDA for delgocitinib cream as a treatment for moderate to severe chronic hand eczema in adults.

This form of eczema tends to crop up on the palms, fingertips, and finger web spaces in the form of a scaly, dry, red and cracking rash. It's often caused by chronic repetitive insults to the skin ...

Apply it to any area in need of a little extra love morning, noon and night. Buy now £48.00, Kate Somerville O'Keeffe's Working Hands Eczema Relief Hand Cream A fan-favourite, wallet-saving ointment ...

LEO Pharma has presented late-breaking data on the DELTA FORCE trial for Anzupgo (delgocitinib) cream as a potential ...

FDA Accepts LEO Pharma’s Filing of Delgocitinib Cream New Drug Application for the Treatment of Chronic Hand Eczema ...

Three eczema warriors share how support from loved ones and the community has helped them navigate the challenges of the skin ...

LEO Pharma’s Anzupgo (delgocitinib) cream has been approved by the European Commission (EC) to treat adults with moderate-to-severe chronic hand eczema (CHE) for whom topical corticosteroids are ...

Singapore's leading specialty pharmaceutical and consumer healthcare group, is pleased to announce the launch of Ceradan ® Advanced Hand Balm, the latest addition to its Ceradan ® line for atopic ...

Ballerup, Denmark Wednesday, September 25, 2024, 17:00 Hrs [IST] ...

A regulatory decision is expected in the second half of 2025. The Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for delgocitinib cream as a treatment ...

Hand eczema, characterized by elevated skin pH and a compromised skin barrier, leaves hands susceptible to inflammation caused by external irritants. The issue is particularly prevalent among ...